Abstract Background Amid increasing opioid overdose deaths in Canada since 2010 and a changing naloxone access landscape, there is a need for up-to-date research on Canadian women’s experiences with opioids. Studies on Canadian take-home naloxone programs are promising, but research beyond these programs is limited. Our study is the first to focus on women’s experiences and perspectives on the opioid crisis in Ontario, Canada’s most populous province, since the opioid crisis began in 2010. Objective Our objective was to address research knowledge gaps involving Canadian women with criminal justice involvement who use opioids, and ide...
Abstract Background: The opioid epidemic was a concern within the United States based upon the risin...
BACKGROUND: Naloxone, an opioid antagonist, offers a powerful tool for preventing opioid overdose de...
Background: Adolescents and young adults (AYA) continue to be impacted by the toxic drug crisis. Thi...
Background: Amid increasing opioid overdose deaths in Canada since 2010 and a chang...
Background: Canada is currently facing an overdose epidemic primarily attributed to prescription and...
The opioid crisis in Canada is increasingly taking the lives of people who use substances and has be...
Abstract Background Drug-induced and drug-related deaths have been increasing for the past decade th...
Drug overdose is currently the leading cause of injury-related death in the United States, outpacing...
Abstract Background Opioid overdose is a leading cause of death among injection drug users. Over hal...
The opioid crisis refers to the significant number of overdoses and deaths in America over the last ...
The number of women experiencing opioid use disorder (OUD) in Canada has increased exponentially. In...
Engagement in take-home naloxone (THN) programs by people receiving opioid substitution treatment (O...
Objective: Take-home naloxone (THN) is recommended in response to pharmaceutical opioid-related mort...
BACKGROUND: Naloxone is a life-saving antidote for opioid overdoses. In June 2016, the Ontario gover...
Introduction: The opioid crisis is widespread and expanding in Ontario. Despite increases in opioid-...
Abstract Background: The opioid epidemic was a concern within the United States based upon the risin...
BACKGROUND: Naloxone, an opioid antagonist, offers a powerful tool for preventing opioid overdose de...
Background: Adolescents and young adults (AYA) continue to be impacted by the toxic drug crisis. Thi...
Background: Amid increasing opioid overdose deaths in Canada since 2010 and a chang...
Background: Canada is currently facing an overdose epidemic primarily attributed to prescription and...
The opioid crisis in Canada is increasingly taking the lives of people who use substances and has be...
Abstract Background Drug-induced and drug-related deaths have been increasing for the past decade th...
Drug overdose is currently the leading cause of injury-related death in the United States, outpacing...
Abstract Background Opioid overdose is a leading cause of death among injection drug users. Over hal...
The opioid crisis refers to the significant number of overdoses and deaths in America over the last ...
The number of women experiencing opioid use disorder (OUD) in Canada has increased exponentially. In...
Engagement in take-home naloxone (THN) programs by people receiving opioid substitution treatment (O...
Objective: Take-home naloxone (THN) is recommended in response to pharmaceutical opioid-related mort...
BACKGROUND: Naloxone is a life-saving antidote for opioid overdoses. In June 2016, the Ontario gover...
Introduction: The opioid crisis is widespread and expanding in Ontario. Despite increases in opioid-...
Abstract Background: The opioid epidemic was a concern within the United States based upon the risin...
BACKGROUND: Naloxone, an opioid antagonist, offers a powerful tool for preventing opioid overdose de...
Background: Adolescents and young adults (AYA) continue to be impacted by the toxic drug crisis. Thi...